Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2014
03/27/2014US20140088020 Composition and Methods for Treatment of Cancer
03/27/2014US20140088016 Macrocyclic therapeutic agents and methods of treatment
03/27/2014US20140088015 Mucin 3 EGF-like Domains
03/27/2014US20140088014 Freeze-dried preparation containing high-purity pth and method for producing same
03/27/2014US20140088013 Complexation of Metal Ions with Polypeptides
03/27/2014US20140088012 Genomic markers for prediction of long-term response to 2 years of growth hormone (gh) therapy
03/27/2014US20140088011 Softgel of NLKJ for treating prostate diseases
03/27/2014US20140088009 Chimeric neuregulins and method of making and use thereof
03/27/2014US20140088007 Composition for the attachment of implants to collagen or other components of biological tissue
03/27/2014US20140088003 Polymer-based sustained release device
03/27/2014US20140088000 Leptin Rescues Neurons from Alzheimer's Disease Related Pathways Triggered by Lipid Burden
03/27/2014US20140087998 Use of pacap for the treatment viral infections in aquatic organisms
03/27/2014US20140087996 Pharmaceutical composition, methods for treating and uses thereof
03/27/2014US20140087992 Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof
03/27/2014US20140087422 Nucleic acids related to fusion proteins
03/27/2014US20140087384 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues
03/27/2014US20140087002 Autologous Lymph Node Transfer In Combination With VEGF-C Or VEGF-D Growth Factor Therapy to Treat Lymphedema And To Improve Reconstructive Surgery
03/27/2014US20140087000 Method and System for Treatment of Biological Tissue
03/27/2014US20140086996 Water-soluble drug carrier and process for producing the same
03/27/2014US20140086994 Synthesis of Small Particles
03/27/2014US20140086988 Stabilized Protein Crystals, Formulations Containing Them and Methods of Making Them
03/27/2014US20140086985 Composition useful for the treatment of lipid metabolism disorders
03/27/2014US20140086979 Self-Assembling Nanoparticles for the Release of Bisphosphonates in the Treatment of Human Cancers
03/27/2014US20140086972 Microfabricated nanopore device for sustained release of therapeutic agent
03/27/2014US20140086946 Uses of an Immunomodulatory Protein (GMI) from Ganoderma Microsporum
03/27/2014US20140086937 Immunological control of beta-amyloid levels in vivo
03/27/2014US20140086936 Matriptase inhibitors and uses thereof against orthomyxoviridae infections
03/27/2014US20140086918 Methods for Inhibiting Prostate Cancer
03/27/2014US20140086907 Multimodal trail molecules and uses in cellular therapies
03/27/2014US20140086905 Immunological compositions as cancer therapeutics
03/27/2014US20140086903 Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
03/27/2014US20140086901 Inhibition of Post-Radiation Tumor Growth
03/27/2014US20140086900 Lyophilized Preparation of Botulinum Toxin
03/27/2014US20140086898 Fragmented polymeric compositions and methods for their use
03/27/2014US20140086897 Chimeric neuregulins and method of making and use thereof
03/27/2014US20140086896 Novel Compositions for Preventing and/or Treating Lysosomal Storage Disorders
03/27/2014US20140086895 Methods and pharmaceutical compositions for the treatment of autoimmune diseases
03/27/2014US20140086886 Stem Cell, Precursor Cell, or Target Cell-Based Treatment of Multi-Organ Failure and Renal Dysfunction
03/27/2014US20140086884 Treatment of diseases and disorders using self-renewing colony forming cells cultured and expanded in vitro
03/27/2014US20140086874 Biomaterial, method for making the biomaterial and uses of the same
03/27/2014US20140086872 Methods of Treating a Subject for a Condition
03/27/2014US20140086868 Use of il-17d for the treatment and prevention of cancers
03/27/2014US20140086855 Combined use of a carnosinase inhibitor with l-carnosine or its related substance and a composition containing the same
03/27/2014US20140086827 Serum S100B And Uses Thereof
03/27/2014US20140086826 Sin3b complex inhibition for preventing hematologic chemotherapy- and radiotherapy-induced cytotoxicity
03/27/2014US20140085998 Composition comprising various proteorhodopsins and/or bacteriorhodopsins and use thereof
03/26/2014EP2711705A1 Oxidized cardiolipin as a novel pro-inflammatory factor
03/26/2014EP2711377A1 Fusion protein for antagonizing angiogenesis inducible factors and uses thereof
03/26/2014EP2711376A1 Fgfr-fc fusion protein and use thereof
03/26/2014EP2711374A1 Novel metalloprotein and process for producing same, and prophylactic or therapeutic agent for corneal and conjunctival diseases comprising said metalloprotein
03/26/2014EP2711025A2 Self-assembling peptides incorporating modifications and methods of use thereof
03/26/2014EP2711023A1 Osteogenesis promoter
03/26/2014EP2711017A1 Immunity inducing agent
03/26/2014EP2711016A1 Novel IL-17A binding molecules and medical uses thereof
03/26/2014EP2711015A1 Immunity induction agent
03/26/2014EP2711012A1 Formulations and methods for recovery from dental surgery
03/26/2014EP2710031A2 Improved peptide pharmaceuticals for insulin resistance
03/26/2014EP2709991A1 Use of cxcr4 antagonists
03/26/2014EP2709728A1 Tau protease compositions and methods of use
03/26/2014EP2709727A1 Method to modulate pigmentation process in the melanocytes of skin
03/26/2014EP2709662A1 Use of anti-cgrp or anti-cgrp-r antibodies or antibody fragments to treat or prevent chronic and acute forms of diarrhea
03/26/2014EP2709654A1 Process for purifying heparan-n-sulfatase
03/26/2014EP2709653A2 Aav mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity
03/26/2014EP2709652A1 Pharmaceutical combination for use in the treatment of diabetes type 2
03/26/2014EP2709651A1 Il-12 p40 monomer, monoclonal antibody against p40 homodimer and the combination of the two for autoimmune disease treatment
03/26/2014EP2709650A2 Hepatocyte growth factor mimics as therapeutic agents
03/26/2014EP2709649A2 Sgef controls macular, corpus callosum and hippocampal function and development, liver homeostasis, functions of the immune system, fever response atherosclerosis and tumorogenic cell growth
03/26/2014EP2709648A2 Compounds that bind to the erythropoietin receptor
03/26/2014EP2709647A1 Water soluble membrane proteins and methods for the preparation and use thereof
03/26/2014EP2709646A1 Dry powder vancomycin compositions and associated methods
03/26/2014EP2709645A2 Improved peptide pharmaceuticals
03/26/2014EP2709644A1 Methods of treating a disorder associated with sequestered bacteria
03/26/2014EP2709641A1 A dietary supplement
03/26/2014EP2709638A1 Honey composition with l-alanyl- l- glutamine
03/26/2014EP2709637A1 Treatment of intervertebral disc degeneration using human umbilical cord tissue-derived cells and hydrogel
03/26/2014EP2709633A1 Method of treatment or prophylaxis of bacterial vaginosis
03/26/2014EP2709603A1 Modified biotin-binding protein, fusion proteins thereof and applications
03/26/2014EP2709595A1 Ifn-beta compositions, preparation methods and uses thereof
03/26/2014EP2613152A9 Sensitizer for an erythrocytic diagnostic agent for diagnosing malignant neoplasms and method for producing same, erythrocytic diagnostic agent for diagnosing malignant neoplasms and method for producing same and method for diagnosing the presence of malignant neoplasms using said erythrocytic diagnostic agent
03/26/2014CN1997388B Mucinous glycoprotein (MUC-1) vaccine
03/26/2014CN1938045B Use of cd40 antibody for treating autoimmune diseases, inflammatory diesease and organ transplanting rejection
03/26/2014CN103687946A Peptide for inducing regeneration of tissue and use thereof
03/26/2014CN103687945A Anti-B7-H3 antibody
03/26/2014CN103687867A Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
03/26/2014CN103687619A Compositions and methods for the therapy and diagnosis of influenza
03/26/2014CN103687610A Wound debridement compositions containing seaprose and methods of wound treatment using same
03/26/2014CN103687609A A heat stable oxygen carrier-containing pharmaceutical composition for different treatment applications
03/26/2014CN103687608A Shk-based pharmaceutical compositions and methods of manufacturing and using the same
03/26/2014CN103687607A Proteolytic extract from bromelain for the treatment of connective tissue disorders
03/26/2014CN103687602A Induction of IL-12 using immunotherapy
03/26/2014CN103687590A Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
03/26/2014CN103667408A Method for preparing intestine nutritive peptide by using wheat
03/26/2014CN103667407A Polypeptide-zinc metal complex as well as preparation method and application thereof
03/26/2014CN103667300A Pichia pastoris-optimized oncorhynchus mykiss hepcidin, oncorhynchus mykiss hepcidin-containing expression carrier, oncorhynchus mykiss hepcidin-containing strain and applications
03/26/2014CN103667230A Enterococcus faecalis phage lyase and coding gene and application thereof
03/26/2014CN103667190A Method for forming nerve cells by induction and composition
03/26/2014CN103667106A Lactobacillus plantarum, bacteriocins and culture, separation and purification method thereof
03/26/2014CN103665170A Peptide therapeutic conjugates and uses thereof
03/26/2014CN103665167A Preparation and application of fused polypeptide of calcitonin gene-related peptide and salmon calcitonin
03/26/2014CN103665166A Dog fusion interferon
1 ... 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 ... 3163